1. Rydén L, Grant PJ, Anker SD. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2013;34:3035-87.
2. Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. N Engl J Med 2013;369:1317-26.
3. Muhlestein JB, Lappe DL, Lima JAC, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA 2014;312:2234-43.
Recommandations
Prise en charge des pneumonies aiguës communautaires
Mise au point
Neuropathie diabétique (2/2) : prise en charge
En 5 points
Pneumocoque, les nouvelles stratégies de vaccination
Étude et Pratique
Perte d’audition liée à l’âge et risque de démence